ERBB2 and breast cancer: Luminal and HER2-positive breast cancer cells predominantly expressed NFYAv2 but had almost undetectable NFYAv1 expression, which was almost the same in normal and basal-like breast cancer cells; NFYAv1 expression was slightly detectable.